November 4, 2022
RegMed Investors’ (RMi) closing bell: strolling a crooked session (10 of 35 covered companies stumbled)
November 3, 2022
RegMed Investors’ (RMi) closing bell: taking it in the shins as sector trips
November 2, 2022
RegMed Investors’ (RMi) closing bell: We waited for Jerome and got the expected .75 basis point rate increase
November 1, 2022
RegMed Investors’ (RMi) closing bell: markets dive as sector thrives, algorithms “rule’ in our favor
October 31, 2022
RegMed Investors’ (RMi) closing bell: falling and feeling more than a pinch as October ends
October 28, 2022
RegMed Investors’ (RMi) closing bell: grabbing onto the upside
October 27, 2022
RegMed Investors’ (RMi) closing bell: I told you the downdraft was coming
October 26, 2022
RegMed Investors’ (RMi) closing bell: sector slips and slides, yet with positive close
October 25, 2022
RegMed Investors’ (RMi) closing bell: the roller-coaster rides to a peak
October 24, 2022
RegMed Investors’ (RMi) closing bell: sector rains on last week’s parade
October 21, 2022
RegMed Investors’ (RMi) closing bell: no ladders needed; the tide went out and today came back in
October 20, 2022
RegMed Investors’ (RMi) closing bell: The upside didn’t last long after Wednesday’s extreme downside from an upside open
October 19, 2022
RegMed Investors’ (RMi) closing bell: wipe-out
October 18, 2022
RegMed Investors’ (RMi) closing bell: a choppy sector session
October 17, 2022
RegMed Investors’ (RMi) closing bell: support levels are back for the oversold, although with low volume
October 14, 2022
RegMed Investors’ (RMi) closing bell: risk and sentiment have broken through cell and gene therapy equities
October 12, 2022
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector share pricing rides the roller-coaster
October 11, 2022
RegMed Investors’ (RMi) closing bell: an oversold bounce from nowhere to close neutral in my coverage group
October 10, 2022
RegMed Investors’ (RMi) closing bell: “Waiting for Godot” gets replaced by Jerome Powell in the offing
October 7, 2022
RegMed Investors’ (RMi) closing bell: negative reaction
October 6, 2022
RegMed Investors’ (RMi) closing bell: no, good and bad news makes little difference in sector pricing
October 5, 2022
RegMed Investors’ (RMi) closing bell: another I warned you so …
October 4, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector ballooned-up
October 3, 2022
RegMed Investors’ (RMi) closing bell: snap, crackle and a pop
5 hours 23 min ago
RegMed Investors’ (RMi) pre-open: Waiting for PPI, it's here
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.